Τίτλος:
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Evangelopoulos, M.E.
Miclea, A.
Schrewe, L.
Briner, M.
Salmen, A.
Engelhardt, B.
Huwiler, A.
Chan, A.
Hoepner, R.
Περιοδικό:
CNS Neuroscience and Therapeutics
Εκδότης:
Wiley-Blackwell Publishing Ltd
Λέξεις-κλειδιά:
cyclophosphamide; fingolimod; fumaric acid dimethyl ester; gadolinium; glatiramer; liver enzyme; natalizumab; rituximab; fingolimod; immunosuppressive agent, adult; adverse outcome; brain disease; clinical article; cohort analysis; disease course; disease severity; drug half life; drug withdrawal; epidemiology; fatigue; female; human; Letter; lymphocytopenia; male; middle aged; morbidity; motor dysfunction; multiple sclerosis; neoplasm; neuroimaging; nuclear magnetic resonance imaging; patient preference; phenotype; recurrent disease; retrospective study; risk assessment; risk factor; sensory dysfunction; Switzerland; treatment withdrawal; university hospital; unspecified side effect; multiple sclerosis; recurrent disease; withdrawal syndrome, Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Recurrence; Retrospective Studies; Substance Withdrawal Syndrome
